Clinical Trial Update: Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing a vaccine therapy with interferon alfa in patients with stage III melanoma; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon Alfa (interferon alfa)
• vaccine therapy (unspecified)

Snippet

Sponsor: AVAX Technologies | Conditions: Melanoma (Skin) | Phase 2 | Status: TERMINATED